News & Views
New vaccines could save millions but need funding
Jun 09 2011
According to articles in the June 2011 edition of Health Affairs, funded by a grant from the Bill & Melinda Gates Foundation, despite the investment in the life-saving vaccines, scientists have much to do to ensure they are developed, delivered and supplied.
Product development and financing models have been essential in the effort to increase vaccine development and deliver the treatments to developing countries.
Further research is needed by scientists into potential new vaccines, the source suggested, with this decade offering potential vaccines against diseases such as typhoid, malaria, and dengue.
In the next three to five months, teams of scientists will need investments in order to get the innovative vaccines through a series of clinical laboratory trials and regulatory hurdles.
However, without improvements to supply-chains, the lives of millions of people who need vaccines will be put at risk, independent consultant Judith Kaufmann, Roger Miller of LMI, and independent consultant James Cheyne told the journal.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE